The value of patient-reported outcomes in lung cancer clinical trials
- PMID: 36590719
- PMCID: PMC9801276
- DOI: 10.1016/j.xjon.2022.10.001
The value of patient-reported outcomes in lung cancer clinical trials
References
-
- Pompili C., Rogers Z., Absolom K., Holch P., Clayton B., Callister M., et al. Quality of life after VATS lung resection and SABR for early-stage non–small cell lung cancer: a longitudinal study. Lung Cancer. 2021;162:71–78. - PubMed
-
- Koller M., Shamieh O., Hjermstad M.J., Hornslien K., Young T., Chalk T., et al. Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study. Lancet Oncol. 2020;21:723–732. - PubMed
LinkOut - more resources
Full Text Sources